Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
C&F Financial | CFFI | Nov 22, 2024 | 74.19 | -0.97 |
C.H. Robinson Worldwide | CHRW | Nov 22, 2024 | 107.61 | -0.86 |
C3.ai | AI | Nov 22, 2024 | 37.42 | +6.94 |
C3is | CISS | Nov 22, 2024 | 0.85 | +1.08 |
C4 Therapeutics | CCCC | Nov 22, 2024 | 4.25 | +5.99 |
Cabaletta Bio | CABA | Nov 22, 2024 | 1.87 | 0.00 |
Cabana Target Drawdown 10 ETF | TDSC | Nov 22, 2024 | 25.89 | +0.30 |
Cabana Target Drawdown 7 ETF | TDSB | Nov 22, 2024 | 22.71 | +0.30 |
Cable One | CABO | Nov 22, 2024 | 416.55 | +3.40 |
Cabot | CBT | Nov 22, 2024 | 110.36 | +1.56 |
CACI International A | CACI | Nov 22, 2024 | 468.78 | -1.41 |
Cactus A | WHD | Nov 22, 2024 | 68.99 | +0.79 |
Cactus Acquisition 1 A | CCTS | Nov 22, 2024 | 11.65 | 0.00 |
Cadeler ADR | CDLR | Nov 22, 2024 | 23.88 | -0.04 |
Cadence Bank | CADE | Nov 22, 2024 | 38.88 | +2.40 |
Cadence Bank A | CADE-A | Nov 22, 2024 | 20.99 | +0.24 |
Cadence Design Systems | CDNS | Nov 22, 2024 | 311.87 | +1.75 |
Cadiz | CDZI | Nov 22, 2024 | 3.37 | +4.98 |
Cadiz Pref ADR | CDZIP | Nov 22, 2024 | 16.20 | -0.03 |
Cadre | CDRE | Nov 22, 2024 | 33.48 | +2.07 |
Cadrenal Therapeutics | CVKD | Nov 22, 2024 | 14.99 | +7.00 |
Cae | CAE | Nov 22, 2024 | 22.90 | -1.76 |
Caesars Entertainment | CZR | Nov 22, 2024 | 37.60 | +0.11 |
Caesarstone | CSTE | Nov 22, 2024 | 4.14 | +4.02 |
Cal-Maine Foods | CALM | Nov 22, 2024 | 95.96 | +0.19 |
Calamos Convertible High Fund | CHY | Nov 22, 2024 | 12.32 | +0.98 |
Calamos Convertible Opportunities And Income Fund | CHI | Nov 22, 2024 | 12.11 | +0.58 |
Calamos Dynamic Convertible & Income Fund | CCD | Nov 22, 2024 | 24.51 | -0.08 |
Calamos Global Dynamic Fund | CHW | Nov 22, 2024 | 7.02 | +0.72 |
Calamos Global Total Return Fund | CGO | Nov 22, 2024 | 11.95 | +0.50 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.